Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine - Ford, Janet H.; Kurth, Tobias; Starling, Amaal J.; Ayer, David W.; Wietecha, Linda A.; Port, Martha D.; Rettiganti, Mallikarjuna; Ruff, Dustin D. (Headache, 2020)
Keywords: Activities of daily living; Calcitonin; calcitonin gene‐related peptide; chronic migraine; Clinical trials; Domains; episodic migraine; galcanezumab; Headache; Headaches; Health services; Migraine; Monoclonal antibodies; Patients; patient‐reported outcomes; Peptide inhibitors; Quality of life; Questionnaires; Research Submission; Research Submissions; Statistical analysis; patient-reported outcomes; calcitonin gene-related peptide; episodic migraine; chronic migraine; galcanezumab